NCT06614257 (REPABS-BPG) is a NA clinical trial of LG-TAP block with local anesthetic in Pain, sponsored by Fondazione Policlinico Universitario Campus Bio-Medico.

Who is sponsoring NCT06614257?

NCT06614257 is sponsored by Fondazione Policlinico Universitario Campus Bio-Medico.

What drugs are being tested in NCT06614257?

Interventions in NCT06614257: LG-TAP block with local anesthetic, Port site infiltration, LG-TAP block with saline solution.

What condition does NCT06614257 study?

NCT06614257 studies Pain, Postoperative Pain, Acute Pain, Analgesia, Bariatric Surgery Candidate, Anesthesia.

Is NCT06614257 still recruiting?

NCT06614257 is currently completed. Last updated 26 September 2024.

Last reviewed 2024-09-26 · How we verify

NCT06614257: REPABS-BPG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

REduced Pain After Bariatric Surgery - Gastric Bypass

Completed NA Last updated 26 September 2024

What this trial tests

NA trial testing LG-TAP block with local anesthetic in Pain in 84 participants. Completed in 8 March 2024.

Timeline

4 January 2022

Primary endpoint
3 March 2024

8 March 2024

Quick facts

Lead sponsor	Fondazione Policlinico Universitario Campus Bio-Medico
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	84
Start date	4 January 2022
Primary completion	3 March 2024
Estimated completion	8 March 2024
Sites	1 location across Italy

Drugs / interventions tested

LG-TAP block with local anesthetic — full drug profile →
Port site infiltration
LG-TAP block with saline solution — full drug profile →

Conditions studied

Pain — all drugs for Pain →
Postoperative Pain — all drugs for Postoperative Pain →
Acute Pain — all drugs for Acute Pain →
Analgesia — all drugs for Analgesia →

Sponsor

Fondazione Policlinico Universitario Campus Bio-Medico

Who can join

18 and older, any sex, with Pain or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to analyze the effect of laparoscopic guided transversus abdominis plane (LG-TAP) block compared to placebo for postoperative analgesia following laparoscopic gastric bypass. One group of participants received a (LG-TAP) block with local anesthetic while the other group received (LG-TAP) block with saline solution (placebo).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of LG-TAP block with local anesthetic

Trials testing the same drug.

NCT06383234 — REduced Pain After Bariatric Surgery - Sleeve Gastrectomy · NA · completed

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Other Fondazione Policlinico Universitario Campus Bio-Medico trials

Trials by the same sponsor.

NCT06873685 — Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life · NA · recruiting
NCT07119437 — Low Impact Laparoscopy In Bariatric Surgery · NA · recruiting
NCT07029126 — Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symp · recruiting
NCT06539000 — Preoperative Risk Score for Postoperative Right Ventricular Dysfunction in Adult Cardiac Surgery · completed
NCT06974474 — Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study. · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06614257 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Campus Bio-Medico
Last refreshed: 26 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614257.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing